Showing 22,152 results

Filters Content type: Editors' picks
HIV testing programmes & uptake

Late HIV diagnosis still an issue in Aotearoa

Editor's pick
Medical Xpress
3 April 2023
How HIV works

HIV can persist for years in myeloid cells of people on antiretroviral therapy

Editor's pick
National Institutes of Health
31 March 2023
Harm reduction

FDA Approves First Over-the-Counter Naloxone Product

Editor's pick
Filter
31 March 2023
Access to healthcare

Religious “Freedom” Laws Are Trying to Drag Us Back to the Height of the AIDS Epidemic

Editor's pick
TheBody
31 March 2023
Mpox (monkeypox)

US tops 1 million mpox vaccine doses given, but coverage lags in risk groups

Editor's pick
CIDRAP
31 March 2023
Injectable & long-acting PrEP

Pharmaceutical corporation ViiV must provide transparency on life-saving HIV-prevention drug

Editor's pick
Médecins Sans Frontières
31 March 2023
Confidentiality, consent & medical ethics

NHS Highland: Personal info of likely HIV patients leaked

Editor's pick
HeraldScotland
30 March 2023
Migrants, refugees & displaced people

UK: Illegal Migration Bill could be ‘death sentence’ for people on HIV/AIDS medication, MPs warn

Editor's pick
Pink News
30 March 2023
Injectable & long-acting HIV treatment

Clinic finds almost half of people who want long-acting HIV treatment don’t initiate it

Editor's pick
CATIE
30 March 2023
PrEP policies & guidelines

Texas judge strikes down major Obamacare provision protecting birth control, PrEP coverage

Editor's pick
STAT
30 March 2023
HIV & criminal law

Uganda’s anti-gay bill will criminalize HIV programs, activists warn

Editor's pick
Devex News
30 March 2023
Combatting stigma

Paul O'Grady: How Lily Savage defied police who raided a pub with rubber gloves

Editor's pick
BBC News
30 March 2023
Injectable & long-acting PrEP

Medicines Patent Pool signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of ViiV Healthcare’s innovative long-acting HIV prevention medicine

Editor's pick
Medicines Patent Pool
30 March 2023
Injectable & long-acting PrEP

Cabotegravir long-acting for PrEP registrations continue in Sub-Saharan Africa

Editor's pick
ViiV press release
29 March 2023
Ageing & HIV

Another survey with HIV long-term survivors. Have we learned anything new?

Editor's pick
San Francisco AIDS Foundation
29 March 2023
HIV in the arts & media

HIV Advocacy on Tik Tok

Editor's pick
POZ
29 March 2023
History of HIV & AIDS

Ward 86 at 40

Editor's pick
POZ
29 March 2023
Global health targets

Africa's TB reduction rate falls short amid slowing global progress

Editor's pick
World Health Organization
29 March 2023
Kidney problems

Study Bite: Renal Impairment on TDF Rare With PrEP, More Common With ART

Editor's pick
TheBodyPro
29 March 2023
Activism & civil society

ACT UP and GLAAD Protest Simon  & Schuster's 'Denialist' HIV Book

Editor's pick
Advocate.com
28 March 2023
How HIV works

New insights into HIV reservoirs and prospects for remission

Editor's pick
Medical Xpress
28 March 2023
Child developmental issues

Auditory Differences Between Children With and Without HIV

Editor's pick
American Journal of Managed Care
27 March 2023
Activism & civil society

HIV charity that supported thousands in Scotland over 30 years to close

Editor's pick
Metro
26 March 2023
Government, leadership & policy

Tennessee’s Rejection of Federal Funds to Curb HIV Alarms Prevention Groups

Editor's pick
The New York Times
24 March 2023